LabCentral Houses Scientific Visionaries
Engaged in Early-Stage Research

Korro Bio

At Korro Bio, our aim is to bring transformative treatments to patients with rare and debilitating diseases by addressing the underlying genetic cause.  We are utilizing the precision provided by nucleic acid-based therapeutics to target responsible sequences within the genetic code.

Korro Bio logo
Website - Coming Soon
  • Andrew Fraley, Ph.D Founder & SVP Technology
  • Nessan Bermingham, Ph.D Founder & President